Value of systemic inflammation-response index in predicting contrast-induced nephropathy in patients with

Cennet Yildiz1, Yasin Yuksel2, Suleyman Cagan Efe3

  • 1Cardiology Department, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Acta Cardiologica
|June 9, 2023
PubMed

Insights

Systemic inflammatory-response index (SIRI) effectively predicts contrast induced nephropathy (CIN) in patients undergoing percutaneous intervention. SIRI demonstrated higher diagnostic power than neutrophil/lymphocyte ratio (NLR) and monocyte/lymphocyte ratio (MLR) for identifying high-risk patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Inflammation Markers

Background:

  • Contrast induced nephropathy (CIN) is a significant complication of procedures using contrast media.
  • Identifying patients at high risk for CIN is crucial for preventative strategies.

Purpose of the Study:

  • To evaluate the predictive value of the systemic inflammatory-response index (SIRI) for the development of CIN.
  • To compare the diagnostic power of SIRI against other inflammatory markers like NLR and MLR.

Main Methods:

  • A cohort of 676 patients with ST-elevation myocardial infarction undergoing primary percutaneous intervention were analyzed.
  • Patients were categorized into groups with and without CIN.
  • Clinical and biochemical data, including SIRI, neutrophil/lymphocyte ratio (NLR), and monocyte/lymphocyte ratio (MLR), were collected and analyzed.

Main Results:

  • Patients who developed CIN were older and had higher levels of creatinine, inflammatory markers (NLR, MLR, SIRI), and hyperlipidaemia.
  • SIRI showed the highest area under the curve (AUC) for predicting CIN, outperforming NLR and MLR.
  • Multivariate analysis identified SIRI and NLR as independent predictors of CIN, with SIRI having a higher odds ratio.

Conclusions:

  • SIRI is a potent predictor of CIN in patients undergoing percutaneous intervention.
  • SIRI offers superior diagnostic power compared to NLR and MLR for identifying patients at risk of CIN.
  • SIRI is a practical tool for clinicians to assess CIN risk.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
38